Gene correlation analysis of a breast cancer cohort showed that higher expression of GRHL2 is correlated with worse relapse-free survival in Luminal A, Luminal B, HER2+, and Basal-like subtypes (Mooney et al., 2017). This evidence concerns the gene GRHL2 and breast carcinoma.